📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

CRISPR/Cas9 DNA cleavage at SNP-derived PAM enables both in vitro and in vivo KRT12 mutation-specific targeting. (2016)

First Author: Courtney DG
Attributed to:  Developing targeted therapeutics for keratinizing skin disorders funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/gt.2015.82

PubMed Identifier: 26289666

Publication URI: http://europepmc.org/abstract/MED/26289666

Type: Journal Article/Review

Volume: 23

Parent Publication: Gene therapy

Issue: 1

ISSN: 0969-7128